Abstract:This study uncovers the key role for nuclear SAMHD1 in slowing hepatocellular carcinoma (HCC) progression. Elevated nuclear SAMHD1 levels in tumors correlate with favorable prognosis, and hepatocyte‐specific SAMHD1 knockout in mice accelerates tumor growth. Mechanistically, SAMHD1 interacts with the nuclear cohesin complex to stall mitosis, independent of its deoxynucleotide triphosphohydrolase dNTPase activity, positioning SAMHD1 as a potential therapeutic target in HCC. Emerging evidence suggests that the sterile alpha‐motif (SAM) and histidine‐aspartate (HD) domain‐containing protein 1 (SAMHD1) is implicated in various cancers, including hepatocellular carcinoma (HCC). However, its precise role in tumor cells and the underlying mechanisms remain unclear. This study aimed to investigate the expression patterns, prognostic values, and functional role of SAMHD1 in HCC progression. We constructed liver tissue microarrays using tumor and paired paratumor tissue specimens from 187 patients with primary HCC. Our findings indicate that nuclear SAMHD1 protein levels are increased in tumors compared to paratumor tissues. Moreover, nuclear SAMHD1 levels decline in advanced tumor stages, with higher SAMHD1 nuclear staining correlating with favorable prognostic outcomes. Hepatocyte‐specific SAMHD1 knockout mice, generated by crossing SAMHD1fl/fl mice with Alb‐cre mice, showed accelerated tumor progression in a diethylnitrosamine (DEN)‐induced HCC model. In hepatoma cell lines, nuclear overexpression of SAMHD1 inhibited cell proliferation by stalling mitosis, independent of its deoxynucleotide triphosphohydrolase (dNTPase) function. Mechanistically, SAMHD1 interacts with the cohesin complex in nucleus, enhancing sister chromatid cohesion during cell division, which delays metaphase progression. Our findings suggest that nuclear SAMHD1 plays a critical role in slowing HCC progression by regulating mitosis, highlighting its potential as a therapeutic target by manipulating cohesin dynamics.

Inhibitory effect of SAMHD1 on production of HBV DNA

IFN-αcould Induce the Expression of SAMHD1 by Down-Regulating Mir-181A

SAMHD1 Expression is Associated with Low Immune Activation but Not Correlated with HIV‑1 DNA Levels in CD4+ T Cells of Patients with HIV‑1

O-GlcNAcylation of SAMHD1 Indicating a Link between Metabolic Reprogramming and Anti-HBV Immunity

Expression changes of SAMHD1 mRNA in PBMC of HIV-1 infected patients and its correlation with level of IFN-αin plasma

A New Mechanism of SAMHD1 Inhibition of HIV-1 Infection by Induction of Autophagy

SAMHD1:a new HIV-1 inhibitory factor

Interferon-Stimulated SAMHD1 Restricts Hepatitis C Virus Replication

Restriction of Exogenous DNA Expression by SAMHD1.

MicroRNA-181 Expression Regulates Specific Post-Transcriptional Level of SAMHD1 Expression in Vitro.

INHIBITION OF HEPATITIS B VIRUS BY COMBINED Sirnas IN VITRO

Interferon-inducible SAMHD1 restricts viral replication through downregulation of lipid synthesis

SAMD4 family members suppress human hepatitis B virus by directly binding to the Smaug recognition region of viral RNA

Nuclear Overexpression of SAMHD1 Induces M Phase Stalling in Hepatoma Cells and Suppresses HCC Progression by Interacting with the Cohesin Complex

Identification Of Natural Splice Variants Of Samhd1 In Virus- Infected Hcc

Effect of RNAi on HBV Replication and Expression

[Effect of the Cytoplasmic DNA Sensor DAI on Replication of Hepatitis B Virus].

The inhibition effect of GLS4JHS on the transcription activity of covalently closed circular DNA in HepAD38 cells

Inhibitory effect of HMGN2 protein on human hepatitis B viral HBeAg and HBsAg expression and DNA replication in HBV-transformed HepG2. 2.15 cell line

SAMD9L Inactivation Promotes Cell Proliferation Via Facilitating G1-S Transition in Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Inhibition of Hepatitis B Virus Replication by Hepatocyte Nuclear Factor 4-Alpha Specific Short Hairpin RNA.